ABJ GER Week ended 07 Aug 2026

Weekly Investor Report

ABB LTD. N · Industrials · Electrical Equipment & Parts

Open interactive chart View report data
Latest close 87.48 EUR
2.3% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 7.4% above the Trend Line and sits at 80.4% of its 52-week range. The latest completed week returned 2.3%, after a -3.5% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100.

Setup score 70 out of 100
Latest Close 87.48 EUR 7 Aug 2026
1W Return 2.3% latest completed week
4W Return -3.5% short-term follow-through
12W Return -2.1% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • The trend backdrop is active with a 67-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 1 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.3% Latest completed week; four-week move -3.5%. Indicator stack 100/42 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 60.51% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 0 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 7.4% above the Trend Line and sits at 80.4% of its 52-week range. The latest completed week returned 2.3%, after a -3.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8612-week average 0.88

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.86Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -3.5% over four weeks, -2.1% over 12 weeks, and 56.4% over one year. The current trend has remained active for 67 consecutive weeks.

Performance by holding period

1W2.3%
4W-3.5%
12W-2.1%
26W21.5%
52W56.4%
Active trend streak67 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-100.0%Four-week change in activity pressure.
Leadership11.61Latest relative-leadership reading.
RS change-53.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength40/100Blend of value, momentum, and quality. Underlying universe rank 61; rank 1 is best.
Value6/100Relative valuation strength. Underlying universe rank 95; rank 1 is best.
Quality85/100Profitability and accounting quality. Underlying universe rank 16; rank 1 is best.
Momentum88/100Medium-term price momentum. Underlying universe rank 13; rank 1 is best.
Growth83/100Revenue and earnings growth. Underlying universe rank 18; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework29/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
32.7x
Price divided by trailing earnings.
Price / sales
4.7x
Market value relative to trailing revenue.
EV / EBITDA
22.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
40.6%
Gross profit retained from each unit of revenue.
Operating margin
16.8%
Operating profit retained from revenue.
Free-cash-flow margin
11.2%
Free cash flow generated from revenue.
Return on invested capital
20.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
8.6%
Latest one-year revenue growth.
EPS growth
21.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
15.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.1%
Cash dividends relative to market value.
Buyback yield
0.8%
Net share repurchases relative to market value.
Shareholder yield
2.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

0 positive · 0 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.1%Distance below the 52-week high.
13-week volatility3.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+9.0%Week of 10 Apr.
Worst week-7.0%Week of 6 Mar.
Latest week+2.3%Week of 7 Aug.

Shape of recent returns

Strong gains5
Modest gains10
Flat weeks0
Modest losses8
Sharp losses3
Recent vol3.1%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split34/18Count of positive and negative weeks in the 52-week window.
Average skew2.7% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape75/100

Trend, activity pressure, participation, and risk combine to a 75/100 tape read.

 Indicator analysis85/100

Latest 12-week confirmation: trend 12/12, activity pressure 11/12, relative leadership 12/12.

Activity pressure 0.86; 1 reversal markers Next-Week ExpectancyPositive 60.51%

Next-week expectancy is positive with a 60.51% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors53/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 30 SVQF29/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 268.0 of 375 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202687.48 EUR2.3%81.46 EUR39.02 EUR0.0011.6132.2KOn
31 Jul 202685.52 EUR-0.4%80.67 EUR38.57 EUR0.0412.7828.6KOn
24 Jul 202685.90 EUR0.2%79.88 EUR38.14 EUR0.1316.4331.7KOn
17 Jul 202685.76 EUR-5.4%79.11 EUR37.70 EUR0.2218.3527.0KOn
10 Jul 202690.62 EUR-3.3%78.31 EUR37.26 EUR0.3024.8416.0KOn
3 Jul 202693.72 EUR2.6%77.34 EUR36.79 EUR0.3526.843.3KOn
26 Jun 202691.34 EUR-3.0%76.28 EUR36.30 EUR0.3630.526.6KOn
19 Jun 202694.16 EUR6.6%75.27 EUR35.82 EUR0.3634.322.4KOn
12 Jun 202688.32 EUR-2.3%74.06 EUR35.33 EUR0.3729.255.1KOn
5 Jun 202690.42 EUR-1.7%73.13 EUR34.88 EUR0.3733.046.5KOn
29 May 202691.94 EUR-0.2%72.10 EUR34.41 EUR0.3534.9328.6KOn
22 May 202692.14 EUR3.1%71.15 EUR33.93 EUR0.3537.9719.3KOn
15 May 202689.34 EUR-0.4%70.18 EUR33.45 EUR0.3540.6426.1KOn
8 May 202689.70 EUR4.4%69.28 EUR32.99 EUR0.3540.6284.0KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context